U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 6

1.

A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

(Submitter supplied) Cardiac pathological hypertrophy is associated with a significantly increased risk of coronary heart disease and has been observed in diabetic patients treated with rosiglitazone, whereas most published studies do not suggest a similar increase in risk of cardiovascular events in pioglitazone-treated diabetic subjects. This study sought to understand the pathophysiological mechanisms underlying the disparate cardiovascular effects of rosiglitazone and pioglitazone and yield knowledge as to the causative nature of rosiglitazone-associated cardiac hypertrophy.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6885
16 Samples
Download data: TXT
Series
Accession:
GSE48977
ID:
200048977
2.

Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality

(Submitter supplied) The type 2 diabetes medication, rosiglitazone, has come under scrutiny for possibly increasing the risk of cardiac disease and death. To investigate the effects of rosiglitazone on the diabetic heart, we performed cardiac transcriptional profiling of a murine model of type 2 diabetes, the C57BL/KLS-leprdb/leprdb (db/db) mouse. We compared cardiac gene expression profiles from three groups: untreated db/db mice (db-c), db/db mice after rosiglitazone treatment (db-t), and non-diabetic db/+ mice.
Organism:
Mus musculus
Type:
Expression profiling by array
Dataset:
GDS4990
Platform:
GPL4134
15 Samples
Download data: TXT
Series
Accession:
GSE36875
ID:
200036875
3.
Full record GDS4990

Diabetic db/db heart response to rosiglitazone

Analysis of hearts from obese diabetic C57BL/KsJ-db/db mice following treatment with rosiglitazone, a medication for type 2 diabetes. Results provide insight into the molecular basis of the cardiac decompensation associated with both diabetes and rosiglitazone treatment.
Organism:
Mus musculus
Type:
Expression profiling by array, log10 ratio, 2 agent, 2 genotype/variation sets
Platform:
GPL4134
Series:
GSE36875
15 Samples
Download data: TXT
4.

Expression data from Bama minipig hearts - high-fat, high-sucrose diet

(Submitter supplied) In order to study the heart disorder that the long term, high energy diet caused, Bama miniature pigs were fed a high-fat, high-sucrose diet for 23 months. These pigs developed symptoms of metabolic syndrome and showed cardiac steatosis and hypertrophy with a greatly increased heart weight (1.82-fold, P<0.05) and heart volume (1.60-fold, P<0.05) compared with the control pigs. To understand the molecular mechanisms of cardiac steatosis and hypertrophy, nine pig heart cRNA samples were hybridized to porcine GeneChips.
Organism:
Sus scrofa
Type:
Expression profiling by array
Platform:
GPL3533
9 Samples
Download data: CEL, CHP, TXT
Series
Accession:
GSE67890
ID:
200067890
5.

Transcriptomic analysis of PPARalpha-dependent alterations during cardiac hypertrophy

(Submitter supplied) Findings suggest that PPARalpha plays a decisive role in the development of hypertrophy, affecting the functional outcome of the heart. Unfortunately, information on the nature of PPARalpha-dependent processes in cardiac hypertrophy is fragmentary and incomplete. The primary aim of this study was to identify the processes and signaling pathways regulated by PPARalpha in hearts challenged by a chronic pressure overload by means of whole genome transcriptomic analysis. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Dataset:
GDS3465
Platform:
GPL1261
16 Samples
Download data: CEL
Series
Accession:
GSE12337
ID:
200012337
6.
Full record GDS3465

PPARalpha deficient heart response to chronic pressure overload

Analysis of heart left ventricles subjected to chronic pressure overload for 28 days to induce cardiac hypertrophy. PPARalpha mitigates cardiac hypertrophy. Results provide insight into processes and signalling pathways regulated by PPARalpha in hearts challenged by chronic pressure overload.
Organism:
Mus musculus
Type:
Expression profiling by array, count, 2 genotype/variation, 2 stress sets
Platform:
GPL1261
Series:
GSE12337
16 Samples
Download data: CEL
DataSet
Accession:
GDS3465
ID:
3465
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=23|qty=3|blobid=MCID_6735392ab31eac71f547360e|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center